Chronic Hepatitis B

Introduction

If you have been told that you have chronic hepatitis B, you are likely thinking about what the diagnosis means for your liver, your day-to-day life, and the years ahead. The good news is that chronic hepatitis B is now a well-understood condition. With regular monitoring and, when needed, modern antiviral medication, most people live full, active lives and never develop serious liver complications.

This guide is written for adults who have been diagnosed with chronic hepatitis B, and for parents of children living with the infection. It explains what the virus does inside the liver, how doctors decide whether and when to start treatment, what long-term monitoring looks like, and how to lower the risk of complications such as cirrhosis (severe liver scarring) and liver cancer. It also covers practical questions about family, pregnancy, vaccination of close contacts, and daily life.

Hepatitis B is a viral infection of the liver caused by the hepatitis B virus (HBV). When the virus is first acquired, the infection is called acute hepatitis B. Most adults who catch the virus clear it on their own within a few months and develop lifelong immunity. However, when the immune system cannot clear the virus and it remains active in the liver for more than six months, the infection is called chronic hepatitis B.

In chronic infection, the virus lives inside liver cells (hepatocytes) and continues to make copies of itself. The body’s immune system reacts to the infected cells, which can cause ongoing inflammation. Over many years, this inflammation can damage the liver, leading to scarring (fibrosis), advanced scarring (cirrhosis), or, in some people, liver cancer. The risk of these complications varies widely from person to person and depends on factors such as the level of virus in the blood, the degree of liver inflammation, age, sex, family history, and other liver-related conditions.

It is important to understand that chronic hepatitis B is not a single, unchanging state. It moves through different phases over time. In some phases the virus is highly active and the liver is inflamed; in others, the virus is quiet and the liver looks largely normal. The aim of specialist care is to identify which phase you are in, track how it changes, and intervene when treatment is likely to protect your liver.

According to the World Health Organization (WHO), hundreds of millions of people worldwide live with chronic hepatitis B. Many do not know they have it, because the infection can be silent for years.

Phases of Chronic Hepatitis B

Major liver societies, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL), describe chronic hepatitis B as moving through several recognised phases. You do not need to memorise these, but understanding them helps make sense of blood test results and treatment decisions.

HBeAg-Positive Chronic Infection (“Immune Tolerant” Phase)

This phase is most often seen in people who acquired the virus at birth or in early childhood. The virus is replicating at very high levels, but the immune system is not strongly attacking infected liver cells. Liver enzymes (ALT) are usually normal, and there is little or no liver damage. Treatment is generally not recommended during this phase, but careful monitoring is.

HBeAg-Positive Chronic Hepatitis (“Immune Active” Phase)

Here, the immune system is actively fighting the virus. Liver enzymes rise, viral levels remain high, and inflammation can damage the liver. This is one of the phases where doctors most often recommend starting antiviral treatment.

HBeAg-Negative Chronic Infection (“Inactive Carrier” Phase)

The virus has become quiet. Viral levels are low, liver enzymes are normal, and the liver is generally not inflamed. Many people remain stable in this phase for years. Treatment is usually not needed, but lifelong follow-up is, because the virus can reactivate.

HBeAg-Negative Chronic Hepatitis (Reactivation Phase)

The virus becomes active again, with rising viral levels and liver enzyme abnormalities. Liver damage can accumulate during this phase, and antiviral therapy is often considered.

Resolved Hepatitis B (HBsAg Loss)

In a small number of people, the surface antigen of the virus (HBsAg) disappears from the blood over time. This is sometimes called a “functional cure.” The virus is not fully eliminated from the liver, but its activity is very low. Liver cancer screening may still be recommended in people who had cirrhosis or other risk factors.

Causes and Risk Factors

Chronic hepatitis B is caused by infection with the hepatitis B virus. The virus is passed from person to person through blood and certain body fluids.

How the Virus Is Transmitted

• From mother to baby at birth — this is the most common route of chronic infection worldwide, because babies and young children are much more likely than adults to develop chronic infection rather than clear the virus
• Close household contact with an infected person, particularly during childhood, including sharing items that may have traces of blood (razors, toothbrushes, nail clippers)
• Unprotected sexual contact with an infected partner
• Exposure to infected blood through unsafe injections, unscreened blood transfusions (rare in modern healthcare), needle-stick injuries, or shared injecting equipment
• Unsafe medical, dental, or cosmetic procedures, including tattooing or piercing with unsterile equipment

Risk Factors for the Infection Becoming Chronic

The risk that an acute infection becomes chronic depends strongly on age at the time of infection:

• About 90% of babies infected at birth develop chronic hepatitis B
• About 25–50% of children infected between ages one and five develop chronic infection
• Fewer than 5% of healthy adults who catch hepatitis B develop chronic infection

People with weakened immune systems — for example, those on certain immunosuppressive medications, organ transplant recipients, or people living with HIV — are more likely to develop chronic infection at any age.

Hepatitis B is not spread by casual contact, sharing meals, hugging, kissing, coughing, sneezing, or breastfeeding (when standard precautions are followed). Knowing this matters because stigma and fear of transmission are common and largely unfounded.

Signs, Symptoms, and Progression Awareness

Many people with chronic hepatitis B feel completely well for years or even decades. The liver has a large reserve capacity, and significant damage can build up before symptoms appear. Because of this, regular monitoring is the main way to detect problems early, not waiting for symptoms.

Symptoms That May Occur

• Persistent tiredness
• Mild discomfort in the upper right side of the abdomen
• Reduced appetite
• Nausea or feeling generally unwell
• Joint aches

These symptoms are non-specific and can have many causes. They are not, on their own, a sign of advancing liver disease.

Signs of Advanced Liver Disease

The following signs may suggest that the liver is no longer working well and should prompt urgent contact with your specialist:

• Yellowing of the skin or the whites of the eyes (jaundice)
• Dark urine or pale stools
• Swelling of the abdomen or legs
• Easy bruising or bleeding, or vomiting blood
• Confusion, drowsiness, or disturbed sleep patterns
• Unintentional weight loss

If you experience any of these, you should contact your liver specialist or seek medical attention promptly.

Diagnosis and Evaluation

If you already have a diagnosis of chronic hepatitis B, you have likely had several of the following tests. They are also used regularly during follow-up to track the condition.

Blood Tests for Hepatitis B

A panel of blood tests is used to confirm chronic hepatitis B and to understand its current phase:

• HBsAg (hepatitis B surface antigen) — a positive result lasting more than six months confirms chronic infection
• Anti-HBs — shows immunity, either from past infection that has resolved or from vaccination
• Anti-HBc (total and IgM) — shows past or recent exposure to the virus
• HBeAg and anti-HBe — help define the phase of infection
• HBV DNA (viral load) — measures how actively the virus is replicating

Liver Function and Damage Assessment

• Liver enzymes (ALT, AST) — raised levels suggest active liver inflammation
• Albumin, bilirubin, and clotting tests — assess how well the liver is functioning overall
• Platelet count — can drop when scarring is advanced
• Alpha-fetoprotein (AFP) — sometimes used in liver cancer screening alongside imaging

Imaging and Fibrosis Assessment

• Liver ultrasound — the most common imaging test, used to look at the liver structure and screen for liver cancer
• Transient elastography (FibroScan) or shear-wave elastography — a quick, painless test that measures liver stiffness as an indicator of scarring
• CT or MRI scans — used when ultrasound findings need clarification or when liver cancer is suspected
• Liver biopsy — sampling a small piece of liver tissue, used less often than in the past because non-invasive tests have improved, but still useful in selected cases

Screening for Co-Infections

Because hepatitis B shares routes of transmission with other infections, specialists routinely screen for:

• Hepatitis C virus
• Hepatitis D virus (which can only infect people who already have hepatitis B and can make liver disease worse)
• HIV

The combined picture from these tests guides whether treatment is needed now, how often you should be monitored, and how often you need imaging.

Treatment and Management

The aim of treating chronic hepatitis B is not always to eliminate the virus — current medicines rarely achieve a complete cure. Instead, the goals described by AASLD, EASL, and WHO are to suppress viral replication, calm liver inflammation, prevent progression to cirrhosis, lower the risk of liver cancer, and prevent transmission to others.

Who Needs Antiviral Treatment?

Not everyone with chronic hepatitis B needs medication. Major liver societies recommend treatment for people who fall into specific categories, including:

• Those with significant liver inflammation (raised ALT) along with measurable viral activity
• Those with significant fibrosis or cirrhosis, regardless of ALT level
• Pregnant women with high viral loads, to reduce the risk of transmission to the baby
• People about to start immunosuppressive treatment or chemotherapy, to prevent viral reactivation
• People with hepatitis B–related conditions outside the liver, such as certain kidney or skin conditions linked to the virus

People in inactive phases of infection, with low viral load and no liver damage, are usually monitored rather than treated. The decision is reviewed at each visit.

First-Line Antiviral Medications

Modern hepatitis B treatment is well tolerated and taken as a daily tablet. The medications most commonly used as first-line therapy, according to current AASLD and EASL guidance, are:

• Entecavir
• Tenofovir disoproxil fumarate (TDF)
• Tenofovir alafenamide (TAF)

These medicines suppress viral replication very effectively, have a high barrier to resistance, and are generally well tolerated over many years of use. Older medications such as lamivudine, adefovir, and telbivudine are now used less often because resistance develops more easily.

Pegylated Interferon

Pegylated interferon alfa is an injectable treatment given for a fixed period, usually around 48 weeks. It works differently from oral antivirals by stimulating the immune response against the virus. It can produce a more durable off-treatment response in some patients but has more side effects and is not suitable for people with advanced cirrhosis. Whether interferon is an option depends on age, liver health, viral characteristics, and personal preference.

How Long Is Treatment Continued?

For most people, oral antiviral therapy is long-term — often many years and sometimes lifelong. Stopping treatment too early can lead to viral rebound and flares of liver inflammation. Decisions to stop or change therapy are made by the specialist based on blood test trends and overall liver health.

Procedures and Advanced Interventions

Most people never need a procedure for chronic hepatitis B. Procedures and advanced interventions come into play when complications develop:

• Endoscopy to look for and treat enlarged veins in the food pipe (oesophageal varices) in people with cirrhosis
• Procedures to manage fluid build-up in the abdomen (ascites)
• Targeted treatments for early liver cancer, including local ablation, surgical resection, or transarterial therapies
• Liver transplantation in people with advanced liver failure or specific liver cancer situations where transplant is appropriate

Liver transplant centres continue antiviral therapy before and after transplant to prevent reinfection of the new liver.

Monitoring and Long-Term Follow-Up

Typical Monitoring Schedule

The exact schedule depends on your phase of infection, treatment status, and liver health. Broadly, specialists may recommend:

• Liver enzyme tests and HBV DNA every 3 to 6 months for people on treatment or with active disease
• Less frequent monitoring (every 6 to 12 months) for those in inactive phases
• Liver stiffness measurement (FibroScan) every 1 to 2 years, or as advised, to track scarring

Liver Cancer Surveillance

Chronic hepatitis B increases the risk of hepatocellular carcinoma (the most common type of liver cancer). Importantly, this risk exists even without cirrhosis, particularly in people who:

• Acquired the infection in childhood
• Have a family history of liver cancer
• Are older (the risk rises with age)
• Have cirrhosis or significant fibrosis
• Have co-infection with hepatitis C or D, or HIV

Liver cancer surveillance, recommended by AASLD, EASL, and APASL, usually consists of liver ultrasound every six months, sometimes combined with an alpha-fetoprotein blood test. Found early, liver cancer can often be treated with curative intent.

Vaccination of Close Contacts

One of the most important practical steps you can take is to make sure people who live with you or are in close contact — partners, children, household members — are tested and, if not already immune, vaccinated against hepatitis B. The vaccine is safe and highly effective.

Lifestyle and Self-Management

Day-to-day choices can support liver health and reduce the chance of complications. None of these replace medical treatment, but together they make a meaningful difference.

Alcohol

Alcohol directly damages liver cells and, in someone with chronic hepatitis B, accelerates fibrosis and raises the risk of liver cancer. Liver societies advise avoiding alcohol entirely. If reducing or stopping alcohol is difficult, your doctor can help.

Weight, Diet, and Metabolic Health

Fatty liver disease, often linked to overweight, diabetes, and high cholesterol, can combine with hepatitis B to cause more rapid liver damage. Helpful steps include:

• A balanced diet with plenty of vegetables, fruits, whole grains, and adequate protein
• Limiting ultra-processed foods, sugary drinks, and saturated fats
• Achieving and maintaining a healthy weight
• Managing diabetes, blood pressure, and cholesterol with your primary doctor
• Regular physical activity within your ability

There is no specific “hepatitis B diet.” The principles are those of general healthy eating, adjusted in late-stage liver disease where salt and fluid restriction may be necessary.

Medications and Supplements

Some medications and herbal products can be hard on the liver. Always tell any treating doctor that you have chronic hepatitis B, including before:

• Starting new prescription medications, especially long-term painkillers, antibiotics, or chemotherapy
• Taking over-the-counter medicines
• Starting herbal or traditional supplements, which are a common cause of unexpected liver injury

Paracetamol (acetaminophen) is usually safe in low doses, but the maximum daily amount may be lower if you have advanced liver disease — ask your specialist.

Vaccinations

People with chronic hepatitis B are advised to be vaccinated against hepatitis A, because another liver infection on top of hepatitis B can be more severe. Influenza and pneumococcal vaccines are also generally recommended. Discuss vaccinations with your specialist before travel.

Preventing Transmission to Others

• Do not share toothbrushes, razors, nail clippers, or any item that may have traces of blood
• Cover cuts and wounds
• Use condoms with partners who are not vaccinated or immune
• Inform dentists, surgeons, and other healthcare providers so they take standard precautions (they should do so for every patient, but disclosure can streamline care)
• Do not donate blood, organs, or sperm

You can share meals, hug, kiss, work alongside others, and live an ordinary social life. Casual contact does not transmit the virus.

Complications of Chronic Hepatitis B

The aim of long-term management is to prevent the following complications. Knowing what they are helps you understand why monitoring is important.

Cirrhosis

Repeated cycles of inflammation and scarring can eventually replace healthy liver tissue with fibrous scar tissue. When this scarring becomes extensive, the liver structure changes and function becomes impaired. Cirrhosis can be compensated (the liver still functions adequately) or decompensated (signs such as jaundice, fluid build-up, or confusion develop). Antiviral therapy can slow, halt, or in some cases partially reverse fibrosis over years.

Liver Cancer (Hepatocellular Carcinoma)

As discussed above, chronic hepatitis B is one of the leading causes of liver cancer worldwide. Regular surveillance is the most reliable way to detect tumours early, when they are most treatable.

Liver Failure

Advanced liver disease can lead to a state where the liver can no longer perform its essential functions, causing complications such as variceal bleeding, severe ascites, kidney problems, or hepatic encephalopathy (confusion caused by toxins the liver normally clears). At this stage, liver transplantation may be considered.

Hepatitis B Reactivation

If you start immunosuppressive medication, chemotherapy, or certain biologic drugs, the virus can become highly active again, sometimes causing serious liver injury. Hepatitis B testing is recommended before such treatments, and antiviral therapy is often started as a preventive measure.

Conditions Outside the Liver

Chronic hepatitis B can occasionally cause problems elsewhere in the body, including certain types of kidney disease, blood vessel inflammation (vasculitis), and skin conditions. These are less common but recognised.

Pregnancy, Family Planning, and Newborn Care

Chronic hepatitis B and pregnancy are compatible, and with the right precautions the risk of passing the virus to the baby is now very low.

Before Pregnancy

Discuss your medications with your specialist. Some hepatitis B medicines are safer than others in pregnancy. Tenofovir disoproxil fumarate (TDF) has the most reassuring safety data and is the option most often used in pregnancy when treatment is needed.

During Pregnancy

Pregnant women with chronic hepatitis B should have their viral load measured. If the viral load is high, current guidelines from AASLD, EASL, and WHO recommend antiviral therapy in the third trimester to lower the risk of transmission at birth.

At Birth and After

• The first dose of the hepatitis B vaccine
• Hepatitis B immunoglobulin (HBIG), which provides immediate antibody protection

The vaccine series is then completed over the following months. With this combination, the risk of transmission falls dramatically.

Breastfeeding

Breastfeeding is considered safe for babies who have received hepatitis B vaccination and immunoglobulin at birth. WHO and major liver societies support breastfeeding in mothers with chronic hepatitis B, including those on tenofovir-based therapy.

Chronic Hepatitis B in Children

Children with chronic hepatitis B usually acquired the infection at birth or in early childhood. Most have completely normal liver enzymes and no symptoms for many years — the immune-tolerant phase described earlier is particularly common in this group.

Diagnosis and Monitoring

Children are diagnosed with the same blood tests used in adults. Liver biopsy is rarely needed; non-invasive tests such as FibroScan, when available for children, help assess liver stiffness. Specialists track liver enzymes, viral load, and growth and development over time.

Treatment in Children

Most children do not need antiviral medication, particularly during the immune-tolerant phase when the liver is not inflamed. When treatment is indicated — for example, in children with significant ALT elevation or evidence of liver damage — paediatric hepatologists choose medications approved for the relevant age group. Entecavir and tenofovir formulations are commonly used, with the specific choice depending on age and weight. Pegylated interferon is sometimes considered in children over a certain age.

School, Sports, and Daily Life

Children with chronic hepatitis B can attend school, play sports, participate in all normal activities, and be cared for like any other child. The virus is not transmitted through casual school or playground contact. Schools are not required to know about the diagnosis, and disclosing it is a personal decision.

Emotional and Family Considerations

Parents often worry about stigma, the child’s future, and the risk of liver cancer. Honest, age-appropriate conversations — led with the support of the paediatric specialist — help children grow up understanding their condition without shame. Other family members should be tested and, if needed, vaccinated.

Preventing Progression and Protecting Your Liver

Prevention in chronic hepatitis B is not about preventing the infection — that has already occurred. It is about preventing progression to advanced disease and detecting problems early.

Key Preventive Steps

• Attend every scheduled blood test, scan, and specialist visit
• Take antiviral medication exactly as prescribed; never stop without medical advice
• Avoid alcohol
• Maintain healthy weight, blood sugar, and cholesterol
• Get vaccinated against hepatitis A and other recommended infections
• Avoid herbal products and supplements without checking with your specialist
• Inform every doctor and dentist of your diagnosis so they can prescribe and treat safely
• Make sure household and sexual contacts are tested and vaccinated

When to Seek Urgent Medical Attention

Most of the time, chronic hepatitis B is managed through scheduled appointments. However, you should contact your specialist or seek urgent medical care if you develop:

• Yellowing of the skin or eyes
• Confusion, severe drowsiness, or unusual sleep changes
• Vomiting blood or passing black, tarry stools
• Significant abdominal swelling or rapid weight gain from fluid
• Severe abdominal pain
• High fever with feeling very unwell
• Sudden, severe fatigue accompanied by other symptoms

If you stop antiviral treatment for any reason, even briefly, contact your specialist promptly — viral flares can occur when therapy is interrupted.

Living with Chronic Hepatitis B

A hepatitis B diagnosis is lifelong, but it does not define your life. With current treatments, most people maintain normal liver function, normal life expectancy, and full participation in work, family, and travel.

Emotional Wellbeing

It is normal to feel worried, isolated, or stigmatised after diagnosis. Stigma around viral hepatitis is often based on misunderstanding. Talking to a specialist, a counsellor, or a patient support group can help. Many people find that learning about the condition is itself reassuring.

Work, Travel, and Insurance

Chronic hepatitis B does not restrict most occupations. Some specific roles (for example, certain surgical specialties or military positions in some countries) may have additional rules; your specialist can advise. Travel is generally unrestricted, but plan ahead for medication supplies and discuss vaccinations against other infections before trips.

Relationships and Disclosure

Sexual partners should be informed, tested, and vaccinated if not already immune. Once a partner is fully vaccinated and has developed immunity, the risk of transmission becomes very low. Decisions about who else to tell — family, friends, employers — are personal and depend on your circumstances.

Frequently Asked Questions

Is chronic hepatitis B curable?

Current treatments can usually suppress the virus to undetectable levels and prevent liver damage, but a complete cure (eliminating the virus from the body entirely) is uncommon with today’s medications. A “functional cure,” where the surface antigen of the virus disappears from the blood, occurs in a small percentage of people. Research into curative therapies is ongoing.

Will I need to take medication for life?

Some people do, particularly those with cirrhosis or those whose virus rebounds when treatment stops. Others can stop treatment after a defined period, under specialist supervision, if certain blood test criteria are met. Your specialist tailors the duration to your situation.

Can I drink alcohol occasionally?

Liver societies recommend avoiding alcohol entirely in chronic hepatitis B. Even moderate drinking can accelerate liver damage and raise the risk of liver cancer in this group.

Can I have children safely?

Yes. With appropriate antiviral therapy during pregnancy when needed, and with vaccination and immunoglobulin given to the newborn at birth, the risk of passing the virus to the baby is now very low.

Can I breastfeed my baby?

Yes, breastfeeding is considered safe when the baby has received the recommended vaccines and immunoglobulin at birth, including for mothers on tenofovir-based therapy.

Are my family members at risk?

Household members should be tested and vaccinated if they are not already immune. Casual contact at home — sharing meals, hugging, kissing — does not transmit the virus. Personal items that may carry traces of blood, such as razors and toothbrushes, should not be shared.

Do I need a liver biopsy?

Not necessarily. Non-invasive tests such as FibroScan have reduced the need for biopsy in most patients. Biopsy is reserved for situations where the diagnosis or staging is unclear.

Will I get liver cancer?

Most people with well-managed chronic hepatitis B do not develop liver cancer, but the risk is higher than in the general population. Regular surveillance with ultrasound, and often AFP testing, every six months is the standard way to detect cancer early if it does occur.

Can hepatitis B come back if I have cleared it?

The hepatitis B virus persists in tiny amounts in the liver even after the surface antigen disappears from the blood. Reactivation is rare but can occur with strong immune suppression. Your specialist may continue some monitoring, particularly if you ever require chemotherapy or biologic therapy.

Can I exercise normally?

Yes. Regular physical activity is encouraged. Specific restrictions only apply if you have advanced liver disease, in which case your specialist will give individualised advice.

Conclusion

Chronic hepatitis B is a long-term condition, but it is a manageable one. Modern antiviral medications are safe, effective, and well tolerated, and regular monitoring catches problems before they become serious. Most people with chronic hepatitis B live full lives, with normal life expectancy, when they are followed by an experienced specialist and stay engaged with their care plan.

The most important things you can do are simple: keep your appointments, take medication as prescribed, avoid alcohol, look after your overall health, and make sure your close contacts are tested and vaccinated. Your specialist will adjust treatment and monitoring as the condition evolves, and together you can protect your liver for the long term.